References
- 1. WHO Global Report: Mortality attributable to tobacco. Geneva: World Health Organization; 2012. https://apps.who.int/iris/bitstream/handle/10665/44815/9789241564434_eng.pdf;jsessionid=FC463B25A4569645E547277447C0ED33?sequence=1 (1.08.2022).
- 2. Chang CM, Corey CG, Rostron BL, Apelberg BJ. Systematic review of cigar smoking and all cause and smoking related mortality. BMC Public Health 2015;15:390. doi: 10.1186/s12889-015-1617-5.440860025907101
- 3. Rigotti NA, Clair C. Managing tobacco use: the neglected cardiovascular disease risk factor. Eur Heart J 2013;34(42):3259-67. doi: 10.1093/eurheartj/eht352.24014389
- 4. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020;41(2):255-323. doi: 10.1093/eurheartj/ehz486.31497854
- 5. International Diabetes Federation. IDF Diabetes Atlas – 8th edition. 2017. http://diabetesatlas.org/resources/2017-atlas.html (1.08.2022).
- 6. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375(9733):2215-22. doi: 10.1016/S0140-6736(10)60484-9.290487820609967
- 7. Vyas MV, Garg AX, Iansavichus AV, Costella J, Donner A, Laugsand LE, et al. Shift work and vascular events: systematic review and meta-analysis. BMJ 2012;345:e4800. doi: 10.1136/bmj.e4800.340622322835925
- 8. Beauvalet JC, Quiles CL, de Oliveira MAB, Ilgenfritz CAV, Hidalgo MPL, Tonon AC. Social jetlag in health and behavioral research: a systematic review. Chrono Physiol Ther 2017;7:19-31.10.2147/CPT.S108750
- 9. Gamboa Madeira S, Reis C, Paiva T, Moreira CS, Nogueira P, Roenneberg T. Social jetlag, a novel predictor for high cardiovascular risk in blue-collar workers following permanent atypical work schedules. J Sleep Res 2021;30(6):e13380. doi: 10.1111/jsr.13380.928644333942925
- 10. Windak A, Niżankowski R, Lukas W, Tomasik T, Panasiuk L, Florek-Łuszczki M. Raport „Podstawowa opieka zdrowotna w Polsce – diagnoza i projekty zmian”. Lublin: Instytut Medycyny Wsi im. Witolda Chodźki w Lublinie; 2019. http://www.zdrowie.gov.pl/epublikacje/Pobierz/id/57.html (1.08.2022).
- 11. Bujnowska-Fedak M, Sapilak B, Steciwko A. Epidemiologia schorzeń i struktura zachorowań w praktyce lekarza rodzinnego. Family Med Prim Care Rev 2011;13(2):135-9.
- 12. Special Eurobarometer 458 – Attitudes of Europeans towards tobacco and electronic cigarettes. European Commission. Brussels: Directorate-General for Communication; 2017. https://ec.europa.eu/commfrontoffice/publicopinion/index.cfm/ResultDoc/download/DocumentKy/79002 (4.08.2022).
- 13. Polakowska M, Kaleta D, Piotrowski W, Topór-Mądry R, Puch-Walczak A, Niklas A, et al. On Behalf Of Wobasz Investigators. Tobacco smoking in Poland in the years from 2003 to 2014. Multicentre National Population Health Examination Survey (WOBASZ). Pol Arch Intern Med 2017;127(2):91-9. doi: 10.20452/pamw.3896.28224973
- 14. Zdrojewski T, Rutkowski M, Bandosz P, Gaciong Z, Solnica B, Drygas W. Ocena rozpowszechnienia i kontroli czynników ryzyka chorób serca i naczyń w Polsce – badania NATPOL 1997, 2002, 2011. In: Kopeć G, Jankowski P, Pająk A, Drygas W, editors. Epidemiologia i prewencja chorób układu krążenia. Kraków: Medycyna Praktyczna; 2015. p. 57-64.
- 15. Podolec P, Kopeć G. The prevalence of tobacco smoking amongadult Poles – results of the POLSCREEN study. In: Cieśliński A, Pająk A, Podolec P, Rynkiewicz A, editors. Nationwide Program of the Coronary Artery Disease Prevention POLSCREEN. Poznań: Termedia; 2006. p. 69-79.
- 16. Sulicka J, Fornal M, Gryglewska B, Wizner B, Grodzicki T. Wybrane czynniki ryzyka chorób sercowo-naczyniowych u pacjentów podstawowej opieki zdrowotnej. Arterial Hypertension 2006;10(5):370-6.
- 17. Pinkas J, Kaleta D, Zgliczyński WS, Lusawa A, Wrześniewska-Wal I, Wierzba W, et al. The prevalence of tobacco and e-cigarette use in Poland: a 2019 nationwide cross-sectional survey. Int J Environ Res Public Health 2019;16(23):4820. doi: 10.3390/ijerph16234820.692652131801221
- 18. Poznańska A, Rabczenko D, Wojtyniak B. Wybrane czynniki ryzyka zdrowotnego związane ze stylem życia. In: Sytuacja zdrowotna ludności Polski i jej uwarunkowania. Warszawa: PZH; 2012. https://www.pzh.gov.pl/najnowszy-raport-nizp-pzhsytuacja-zdrowotna-ludnosci-polski-i-jejuwarunkowania/ (4.08.2022).
- 19. Chen A, Machiorlatti M, Krebs NM, Muscat JE. Socioeconomic differences in nicotine exposure and dependence in adult daily smokers. BMC Public Health 2019;19(1):375. doi: 10.1186/s12889-019-6694-4.644822830943945
- 20. Najder A. Sense of coherence, smoking status, biochemical cardiovascular risk factors and body mass in blue collar workers – short report. Am J Mens Health 2018;12(4):894-9. doi: 10.1177/1557988317748393.613146829313407
- 21. IDF Diabetes Atlas – 9th ed. International Diabetes Federation; 2019. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9efinal-web.pdf (5.08.2022).
- 22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5-20. doi: 10.2337/diacare.26.2007.s5.12502614
- 23. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010;1(5):212-28. doi: 10.1111/j.2040-1124.2010.00074.x.402072424843435
- 24. NFZ o zdrowiu. Cukrzyca. Warszawa: Narodowy Fundusz Zdrowia; 2019. https://shiny.nfz.gov.pl/cukrzyca/ (5.08.2022).
- 25. Topor-Madry R, Wojtyniak B, Strojek K, Rutkowski D, Bogusławski S, Ignaszewska-Wyrzykowska A, et al. Prevalence of diabetes in Poland: a combined analysis of national databases. Diabet Med 2019;36(10):1209-16. doi: 10.1111/dme.13949.30889281
- 26. Walicka M, Chlebus M, Brzozowska M, Śliwczyński A, Jędrzejczyk T, Kania L, et al. Prevalence of diabetes in Poland in the years 2010–2014. Clin Diabetol 2016;4(6):232-7. doi: 10.5603/DK.2015.0031.
- 27. Polakowska M, Piotrowski W. Incidence of diabetes in the Polish population: results of the Multicenter Polish Population Health Status Study – WOBASZ. Pol Arch Med Wewn 2011;121(5):156-63.10.20452/pamw.1047
- 28. Rutkowski M, Bandosz P, Czupryniak L, Gaciong Z, Solnica B, Jasiel-Wojculewicz H, et al. Prevalence of diabetes and impaired fasting glucose in Poland – the NATPOL 2011 Study. Diabet Med 2014;31(12):1568-71. doi: 10.1111/dme.12542.24975751
- 29. Zdrojewski T, Bandosz P, Szpakowski P, Konarski R, Jakubowski Z, Manikowski A. Prevalence of main cardiovascular risk factorsin Poland. The NATPOL PLUS study. Kardiol Pol 2004;61:546-58.
- 30. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th ed. Diabetes Res Clin Pract 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.31518657